EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, PCSA: Processa Pharmaceuticals Inc

04 Nov 25 05:36
LAST:

0.3630

CHANGE:
 0.01		OPEN:
0.3748		HIGH:
0.3788		ASK:
22.0800		VOLUME:
23.3K
CHG(%):
2.05		PREV:
0.3706		LOW:
0.3601		BID:
14.7200		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
04 Nov 250.37480.37880.36010.363023.3K
03 Nov 250.41000.41000.36690.37013.64M
31 Oct 250.37150.39950.36000.38904.16M
30 Oct 250.33300.39240.33000.35459.65M
29 Oct 250.31490.43370.31490.389325.98M
28 Oct 250.30550.32000.29860.31581.76M
27 Oct 250.29800.32000.29230.31102.76M
24 Oct 250.30840.33970.29310.31024.65M
23 Oct 250.27600.31500.27500.30653.67M
22 Oct 250.27370.29000.27110.27825.91M

COMPANY PROFILE

Name:Processa Pharmaceuticals Inc
About:Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment. Its drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms of killing the cancer cells. The company's pipeline includes three chemotherapy drugs comprising Gemcitabine, PCS3117 that has completed Phase 2a clinical trials to treat pancreatic, biliary tract, lung, ovarian, breast, and other cancers; Capecitabine, a combination of PCS6422 and capecitabine, which is in Phase 2 clinical trials to treat metastatic colorectal, gastrointestinal, breast, pancreatic, and other cancers; and Irinotecan, PCS11T that is in pre-clinical studies to treat lung, colorectal, gastrointestinal, pancreatic, and other cancers. It also develops non-oncology drugs consisting of PCS12852 that is in Phase 2B clinical trials for treatment of gastroparesis; and PCS499 for the treatment of glomerular disease. The company has license agreements with Elion Oncology, Inc.; Ocuphire Pharma, Inc.; Aposense, Ltd.; Yuhan Corporation; and CoNCERT Pharmaceuticals, Inc. Processa Pharmaceuticals, Inc. was founded in 2017 and is based in Hanover, Maryland.
Sector:Healthcare
Industry:Biotechnology
Address:7380 Coca Cola Drive, Hanover, MD, United States, 21076
Website:https://www.processapharmaceuticals.com
CUSIP:74275C205
CIK:0001533743
ISIN:US74275C2052
FIGI:BBG003MN5ZP8

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.372.7%
MA10:0.347.2%
MA20:0.361.3%
MA50:0.2736.1%
MA100:0.2547.0%
MA200:0.3213.4%
STO9:42.85
STO14:53.25
RSI14:43.32
WPR14:-25.47
MTM14:0.00
ROC14:0.00 
ATR:0.05 
Week High:0.4319.5%
Week Low:0.3021.6%
Month High:0.5756.9%
Month Low:0.2113.4%
Year High:1.50313.2%
Year Low:0.15142.0%
Volatility:116.93 

RECENT SPLITS

Date Ratio
22 Jan 20241-20
23 Dec 20191-7
26 Dec 20171-7
08 Dec 20171-7